| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in cell-based therapies and product innovations are driving significant progress in treatment options, particularly in the fields of ophthalmology and chronic diseases like COPD. The successful launch of Dupixent in Japan highlights the commitment to enhancing therapeutic solutions and meeting patient needs. These developments underscore a robust pipeline of innovative projects at Regeneron, positioning the company favorably in the competitive landscape. However, the evolving regulatory environment and potential market access challenges could pose risks to the timely execution of these innovations. |
| The price action of Regeneron Pharmaceuticals (REGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for REGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2025-03-31. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| REGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0%(0%) | 0 | 0% | 0.5 | 4.2 | -1 | |||||||
| 2025-03-28 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-03-27 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-03-26 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-03-25 | 0%(0%) | 0 | 0% | -0.3 | -0.5 | -1 | |||||||
| 2025-03-24 | 0%(0%) | 0 | 0% | -0.3 | -0.5 | -1 | |||||||
| 2025-03-21 | 0%(0%) | 0 | 0% | -0.3 | -0.5 | -1 | |||||||
| 2025-03-18 | 0%(0%) | 0 | 0% | -0.8 | -3.7 | -1 | |||||||
| 2025-03-17 | 0%(0%) | 0 | 0% | -0.6 | -2.6 | -1 | |||||||
| 2025-03-14 | 0%(0%) | 0 | 0% | -0.6 | -2.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-29 02:22:13 The competition among healthcare companies in the cell-based therapy sector highlights the importance of innovation. |
| 2025-09-29 02:22:13 ALC, GKOS, and REGN are strategically positioned to capture market share in the emerging therapy space. |
| 2025-09-29 02:22:13 The cell-based ophthalmic therapy market is poised for growth, indicating positive trends in healthcare investments. |
| 2025-09-29 02:22:13 Companies like ALC, GKOS, and REGN are attracting investor interest due to their potential in this innovative field. |
| 2025-09-29 02:22:13 The evolving nature of cell-based therapies in ophthalmology showcases significant advancements in medical technology. |